[IMesenteric and mesocolic cystic lymphangiomas. Diagnostic and therapeutic management].
OBJECTIVE
Study of clinical, diagnostic and therapeutic aspects of mesenteric and mesocolic cystic lymphangiomas.


METHODS
15 cases were retrospectively analysed: 5 adults (mean age 36.8 years, range 26 to 46) and 10 children (mean age 23 months, range 0 to 5 years). Diagnosis was prenatal in 1 case. Symptoms were: abdominal pain (80%), fever (20%), abdominal mass (46%), occlusive syndrome (33%), chylous ascitis 1 case. Tumours were mesenteric (86%) or mesocolic (13%).


RESULTS
Complete resection was performed in 11 cases (including 10 bowel resections), incomplete resections in 3 and doxycycline sclerotherapy once. Mean follow-up is 5 years. One recurrence occurred 6 years after complete resection and 1 tumour increased after incomplete resection. Patient treated by sclerotherapy was non symptomatic with a 3.5 years follow-up after last injection.


CONCLUSIONS
Mesenteric and mesocolic cystic lymphangiomas are congenital benign tumours. Complete resection should be performed whenever possible. Intracystic sclerotherapy with doxycyclin is possible for unresectable lymphangiomas.
Mabrut
J Y
JY
Service de chirurgie générale, digestive et de transplantation hépatique, hôpital de la Croix-Rousse, 103, Grande-rue-de-la-Croix-Rousse, 69317 Lyon 04, France. jean-yves.mabrut@chu-lyon.fr
Grandjean
J P
JP
Henry
L
L
Chappuis
J P
JP
Partensky
C
C
Barth
X
X
Tissot
E
E
D015746:Abdominal Pain / Q000209:etiology; D000328:Adult; D003937:Diagnosis, Differential; D005260:Female; D005334:Fever / Q000209:etiology; D006801:Humans; D018191:Lymphangioma, Cystic / Q000175:diagnosis / Q000473:pathology / Q000601:surgery*; D008297:Male; D008646:Mesocolon / Q000473:pathology*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010534:Peritoneal Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000601:surgery*; D011379:Prognosis; D012189:Retrospective Studies; D015911:Sclerotherapy